{"url_path":"/sec/apls/8-k/2026-05-14/item-2-01","section_key":"item-2-01","section_title":"Item 2.01 Completion of Acquisition or Disposition of Assets.","topic":"sec","document":{"doc_type":"8-K","doc_date":"2026-05-14","source_url":"https://www.sec.gov/Archives/edgar/data/1492422/0001193125-26-222923-index.html","accession_number":"0001193125-26-222923","cik":"0001492422","ticker":"APLS","issuer_name":"Apellis Pharmaceuticals, Inc.","edgar_url":"https://www.sec.gov/Archives/edgar/data/1492422/0001193125-26-222923-index.html","primary_entity_key":"0001492422","primary_entity_name":"Apellis Pharmaceuticals, Inc."},"word_count":32,"has_tables":true,"body_markdown":"Item 2.01 Completion of Acquisition or Disposition of Assets.\n\nThe information set forth in the Introductory Note and Item 5.01 of this Current Report on Form 8-K is incorporated herein by reference."}